Drugs / ALX006
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07574385 | Mar → Aug 2026 overdue | toe, misshapen | Rebel Medicine Inc | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALX006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07574385 ↗ |
| Route | Other | “administered as ultrasound-guided sciatic nerve block in the popliteal fossa” NCT07574385 ↗ |